373 related articles for article (PubMed ID: 9464239)
1. Vitamin D receptor gene polymorphisms: analysis of ligand binding and hormone responsiveness in cultured skin fibroblasts.
Gross C; Musiol IM; Eccleshall TR; Malloy PJ; Feldman D
Biochem Biophys Res Commun; 1998 Jan; 242(3):467-73. PubMed ID: 9464239
[TBL] [Abstract][Full Text] [Related]
2. The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants.
Gross C; Krishnan AV; Malloy PJ; Eccleshall TR; Zhao XY; Feldman D
J Bone Miner Res; 1998 Nov; 13(11):1691-9. PubMed ID: 9797477
[TBL] [Abstract][Full Text] [Related]
3. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.
Zhao X; Feldman D
Endocrinology; 1993 Apr; 132(4):1808-14. PubMed ID: 8384998
[TBL] [Abstract][Full Text] [Related]
4. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness.
Malloy PJ; Eccleshall TR; Gross C; Van Maldergem L; Bouillon R; Feldman D
J Clin Invest; 1997 Jan; 99(2):297-304. PubMed ID: 9005998
[TBL] [Abstract][Full Text] [Related]
5. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
6. [Bone density and bone metabolism regulated by vitamin D receptor allele polymorphism in a German study sample].
Baltzer AW; Reinecke J; Wehling P; Granrath M; Schulitz KP
Z Orthop Ihre Grenzgeb; 1999; 137(3):273-9. PubMed ID: 10441835
[TBL] [Abstract][Full Text] [Related]
7. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
8. Tryptophan missense mutation in the ligand-binding domain of the vitamin D receptor causes severe resistance to 1,25-dihydroxyvitamin D.
Nguyen TM; Adiceam P; Kottler ML; Guillozo H; Rizk-Rabin M; Brouillard F; Lagier P; Palix C; Garnier JM; Garabedian M
J Bone Miner Res; 2002 Sep; 17(9):1728-37. PubMed ID: 12211444
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of 1,25-dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25-hydroxyvitamin D3-24-hydroxylase.
Roy S; Martel J; Tenenhouse HS
J Bone Miner Res; 1995 Dec; 10(12):1951-9. PubMed ID: 8619376
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.
Healy KD; Zella JB; Prahl JM; DeLuca HF
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9733-7. PubMed ID: 12900504
[TBL] [Abstract][Full Text] [Related]
11. Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to an opal mutation causing premature termination of the vitamin D receptor.
Zhu W; Malloy PJ; Delvin E; Chabot G; Feldman D
J Bone Miner Res; 1998 Feb; 13(2):259-64. PubMed ID: 9495519
[TBL] [Abstract][Full Text] [Related]
12. The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene.
Arai H; Miyamoto KI; Yoshida M; Yamamoto H; Taketani Y; Morita K; Kubota M; Yoshida S; Ikeda M; Watabe F; Kanemasa Y; Takeda E
J Bone Miner Res; 2001 Jul; 16(7):1256-64. PubMed ID: 11450701
[TBL] [Abstract][Full Text] [Related]
13. Effects of 'non-calcaemic' vitamin D analogues on 24-hydroxylase expression in MG-63 osteoblast-like cells.
Schroeder NJ; Burrin JM; Noonan K; Makin HL; Cunningham J
Nephron Physiol; 2003; 94(4):p62-73. PubMed ID: 12972708
[TBL] [Abstract][Full Text] [Related]
14. Do dietary calcium and age explain the controversy surrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms?
Ferrari SL; Rizzoli R; Slosman DO; Bonjour JP
J Bone Miner Res; 1998 Mar; 13(3):363-70. PubMed ID: 9525336
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor gene polymorphism is associated with urinary calcium excretion but not with bone mineral density in postmenopausal women.
Ongphiphadhanakul B; Rajatanavin R; Chanprasertyothin S; Chailurkit L; Piaseu N; Teerarungsikul K; Sirisriro R; Komindr S; Puavilai G
J Endocrinol Invest; 1997 Nov; 20(10):592-6. PubMed ID: 9438916
[TBL] [Abstract][Full Text] [Related]
16. A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets.
Malloy PJ; Zhu W; Zhao XY; Pehling GB; Feldman D
Mol Genet Metab; 2001 Jun; 73(2):138-48. PubMed ID: 11386849
[TBL] [Abstract][Full Text] [Related]
17. Normal vitamin D receptor concentration and responsiveness to 1, 25-dihydroxyvitamin D3 in skin fibroblasts from patients with absorptive hypercalciuria.
Zerwekh JE; Reed BY; Heller HJ; González GB; Haussler MR; Pak CY
Miner Electrolyte Metab; 1998; 24(5):307-13. PubMed ID: 9705566
[TBL] [Abstract][Full Text] [Related]
18. Consequences of vitamin D receptor regulation for the 1,25-dihydroxyvitamin D3-induced 24-hydroxylase activity in osteoblast-like cells: initiation of the C24-oxidation pathway.
Staal A; van den Bemd GJ; Birkenhäger JC; Pols HA; van Leeuwen JP
Bone; 1997 Mar; 20(3):237-43. PubMed ID: 9071474
[TBL] [Abstract][Full Text] [Related]
19. Autocrine control of vitamin D metabolism in synovial cells from arthritic patients.
Smith SJ; Hayes ME; Selby PL; Mawer EB
Ann Rheum Dis; 1999 Jun; 58(6):372-8. PubMed ID: 10340962
[TBL] [Abstract][Full Text] [Related]
20. 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs.
Musiol IM; Feldman D
Endocrinology; 1997 Jan; 138(1):12-8. PubMed ID: 8977379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
